Drugs / Sorbinil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00000159 | Aug 1983 → ? | diabetes mellitus, diabetic retinopathy | National Eye Institute (NEI) | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sorbinil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000159 ↗ |
| Known as | CP-45,634 | ChEMBL registry synonym — accepted as the source's own label CHEMBL266497 ↗ |
| Known as | NSC-355082 | ChEMBL registry synonym — accepted as the source's own label CHEMBL266497 ↗ |
| Known as | Sorbinilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL266497 ↗ |
| Action | Inhibit | “sorbinil, an aldose reductase inhibitor” NCT00000159 ↗1“Aldose reductase inhibitor” CHEMBL266497 ↗ |
| Modality | Small molecule | — CHEMBL266497 ↗ |
| Target | AKR1B1 | “Aldose reductase inhibitor” CHEMBL266497 ↗ |